Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective

When an innovative product (innovator) is not covered anymore by intellectual property rights, cheaper equivalent medicinal products (generic products) may be marketed and used in clinical practice. The regulation of generic products is well-established, and is primarily based on standard rules for...

Descripción completa

Detalles Bibliográficos
Autores principales: Borg, John Joseph, Tomasi, Paolo, Pani, Luca, Aislaitner, George, Pirozynski, Michal, Leufkens, Hubert, Melchiorri, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientia Pharmaceutica 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475802/
https://www.ncbi.nlm.nih.gov/pubmed/26171329
http://dx.doi.org/10.3797/scipharm.1312-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475802/
https://www.ncbi.nlm.nih.gov/pubmed/26171329
http://dx.doi.org/10.3797/scipharm.1312-10

Ejemplares similares